UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 683

Sortiert nach

Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation

Nature communications, 2015-01, Vol.6 (1), p.6074-6074, Article 6074

2015

Link zum Volltext

Verfügbarkeit prüfen

The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins

Journal of neuroimmunology, 2016-10, Vol.299, p.147-151

2016

Link zum Volltext

Verfügbarkeit prüfen

Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins

Journal of neuroimmunology, 2017-09, Vol.310, p.131-134

Lindsey, J. William

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments

Multiple sclerosis journal - experimental, translational and clinical, 2019-04, Vol.5 (2), p.2055217319855755-2055217319855755

2019

Link zum Volltext

Verfügbarkeit prüfen

Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells

Proceedings of the National Academy of Sciences - PNAS, 2024-01, Vol.121 (3), p.e2315857121

2024

Link zum Volltext

Verfügbarkeit prüfen

The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment

Multiple sclerosis and related disorders, 2023-02, Vol.70, p.104497-104497, Article 104497

2023

Link zum Volltext

Verfügbarkeit prüfen

The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatment

Multiple sclerosis and related disorders, 2021-11, Vol.56, p.103282-103282, Article 103282

2021

Link zum Volltext

Verfügbarkeit prüfen

Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L

Molecular immunology, 2016-01, Vol.69, p.7-12

2016

Link zum Volltext

Verfügbarkeit prüfen

Epstein-Barr virus and multiple sclerosis: Cellular immune response and cross-reactivity

Journal of neuroimmunology, 2010-12, Vol.229 (1), p.238-242

2010

Link zum Volltext

Verfügbarkeit prüfen

Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells

Molecular medicine (Cambridge, Mass.), 2011-01, Vol.17 (1-2), p.95-102

2011

Link zum Volltext

Verfügbarkeit prüfen

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

Neurology, 2008-07, Vol.71 (1), p.35

2008

Link zum Volltext

Verfügbarkeit prüfen

Familial recurrence rates and genetic models of multiple sclerosis

American journal of medical genetics. Part A, 2005-05, Vol.135A (1), p.53-58

Lindsey, J. William

2005

Link zum Volltext

Verfügbarkeit prüfen

Immune regulatory effects of central nervous system antigens in culture

International immunology, 2000-11, Vol.12 (11), p.1605-1612

2000

Link zum Volltext

Verfügbarkeit prüfen

Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.193-193.2

2019

Link zum Volltext

Verfügbarkeit prüfen

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

Annals of neurology, 2007-01, Vol.61 (1), p.14-24

2007

Link zum Volltext

Verfügbarkeit prüfen

Exploring Epstein Barr Virus Connection in Multiple Sclerosis Research: J. William Lindsey, MD

Neurology live (Print), 2024-01

Lindsey, J William

2024

Link zum Volltext

Verfügbarkeit prüfen

Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis

European journal of neurology, 2010-10, Vol.17 (10), p.1263-1269

2010

Link zum Volltext

Verfügbarkeit prüfen

Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

Multiple sclerosis, 2009-02, Vol.15 (2), p.153-158

2009

Link zum Volltext

Verfügbarkeit prüfen

Use of reinduced experimental autoimmune encephalomyelitis to evaluate the importance of epitope spread

International immunology, 1998-06, Vol.10 (6), p.743-748

Lindsey, J W

1998

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study

Multiple sclerosis, 2008-01, Vol.14 (1), p.73-80

2008

Link zum Volltext

Verfügbarkeit prüfen

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Multiple sclerosis, 2006-06, Vol.12 (3), p.309-320

2006

Link zum Volltext

Verfügbarkeit prüfen

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

Neurology, 2009-05, Vol.72 (19), p.1708; author reply 1708

2009

Link zum Volltext

Verfügbarkeit prüfen

Review: PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Multiple Sclerosis Journal, 2008-03, Vol.14 (2), p.147-152

2008

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis: clinical presentation, diagnosis and treatment

American family physician, 1996-09, Vol.54 (4), p.1301

1996

Link zum Volltext

Verfügbarkeit prüfen

Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis

Multiple sclerosis, 2004-06, Vol.10 (3_suppl), p.S73-S78

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 683

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(620)
Mit Volltextzugriff
(603)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation

The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins

Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments

Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells

The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment

The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatment

Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L

Epstein-Barr virus and multiple sclerosis: Cellular immune response and cross-reactivity

Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

Familial recurrence rates and genetic models of multiple sclerosis

Immune regulatory effects of central nervous system antigens in culture

Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

Exploring Epstein Barr Virus Connection in Multiple Sclerosis Research: J. William Lindsey, MD

Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis

Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

Use of reinduced experimental autoimmune encephalomyelitis to evaluate the importance of epitope spread

Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

Review: PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Multiple sclerosis: clinical presentation, diagnosis and treatment

Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis

Suchergebnisse filtern